Ronald van Vollenhoven

机构：Semmelweis University, Karolinska University Hospital, Amsterdam University Medical Centers, University of Amsterdam · ORCID：0000-0001-6438-8663

发表论文 981 篇 · 总被引 71878 次 · h-index 116

代表论文

• A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus (2025 · New England Journal of Medicine · 被引 36)
• Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring (2025 · Arthritis & Rheumatology · 被引 7)
• Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort (2025 · Arthritis Research & Therapy · 被引 7)
• Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective (2025 · RMD Open · 被引 3)
• Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus (2025 · Advances in Therapy · 被引 3)
• Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality (2025 · Annals of the Rheumatic Diseases · 被引 2)